| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
intravenous-mouse LD50 70 mg/kg BEHAVIORAL: COMA
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES Quarterly Journal of Pharmacy & Pharmacology. Vol. 12, Pg. 212, 1939.
oral-mouse LD50 600 mg/kg BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Science Reports of the Research Institutes, Tohoku University, Series C: Medicine. Vol. 36(1-4), Pg. 10, 1989.
oral-rat LD50 1830 mg/kg Personal Communication from P. Schmitz, Bayer AG, 5090 Leverkusen, Bayerwerk, Fed. Rep. Ger., April 4, 1986Vol. 04APR1986
|
| Dermal Toxicity: |
subcutaneous-mouse LD50 360 mg/kg BEHAVIORAL: GENERAL ANESTHETIC
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: TREMOR Quarterly Journal of Pharmacy & Pharmacology. Vol. 12, Pg. 212, 1939.
subcutaneous-rat LD50 400 mg/kg Quarterly Journal of Pharmacy & Pharmacology. Vol. 12, Pg. 212, 1939.
|
| Inhalation Toxicity: |
|
Not determined
|